symbol stringlengths 4 6 | module stringlengths 18 43 | role stringlengths 26 62 | target_to_intervention_score_100 float64 64 97 | tractability_class stringclasses 2
values | model stringlengths 39 77 | primary_assay stringlengths 41 68 | chembl_target_id stringlengths 9 13 ⌀ | pdb_count int64 0 165 | alphafold_url stringlengths 40 44 | recommended_next_experiment stringclasses 10
values |
|---|---|---|---|---|---|---|---|---|---|---|
SNCA | alpha-synuclein aggregation and propagation | central PD pathology target | 97 | highest-priority intervention target | SNCA triplication/A53T iPSC dopaminergic neurons or alpha-synuclein PFF model | pS129 alpha-synuclein, aggregate load, synaptic/neurite phenotypes | CHEMBL6152 | 165 | https://alphafold.ebi.ac.uk/entry/P37840 | Use alpha-synuclein PFF or SNCA-mutant iPSC dopaminergic neurons with pS129 aggregation, synaptic, and viability endpoints. |
GLP1R | metabolic and GLP-1 receptor signalling | repurposing target with phase 2 PD signals | 94 | highest-priority intervention target | dopaminergic neuron stress model with metabolic/inflammatory co-culture | neuronal survival, inflammatory cytokines, mitochondrial respiration | CHEMBL1784 | 56 | https://alphafold.ebi.ac.uk/entry/P43220 | Test GLP-1 agonists in metabolic/inflammatory stress co-culture with neuronal survival, cytokines, and mitochondrial respiration endpoints. |
LRRK2 | LRRK2 kinase and lysosomal stress | genetically anchored kinase target | 90 | highest-priority intervention target | LRRK2 G2019S or R1441C iPSC-derived dopaminergic neurons | phospho-Rab10/Rab12, lysosomal morphology, neurite survival | CHEMBL1075104 | 0 | https://alphafold.ebi.ac.uk/entry/A0A7P0Z4D9 | Test best-supported LRRK2 inhibitors in G2019S iPSC dopaminergic neurons using phospho-Rab10, lysosome, mitochondrial, and neurite endpoints. |
GBA1 | GBA1 lysosome/autophagy | lysosomal enzyme and PD risk gene | 90 | highest-priority intervention target | GBA1-mutant iPSC dopaminergic neurons and macrophage/microglia-like cells | glucocerebrosidase activity, lysosomal pH, alpha-synuclein burden | CHEMBL2179 | 0 | https://alphafold.ebi.ac.uk/entry/A0A0G2JLB3 | Test GCase modulators in GBA1-mutant iPSC dopaminergic neurons using GCase activity, lysosomal pH, alpha-synuclein, and survival endpoints. |
SLC6A3 | dopaminergic synapse | dopamine transporter marker and dopaminergic phenotype readout | 88 | highest-priority intervention target | iPSC dopaminergic neuron maturation/readout assay | DAT expression/function, dopamine uptake, neuron identity QC | CHEMBL238 | 7 | https://alphafold.ebi.ac.uk/entry/Q01959 | Run target-specific perturbation in iPSC dopaminergic neuron maturation/readout assay using DAT expression/function, dopamine uptake, neuron identity QC. |
TLR2 | innate immune signalling | Reactome-highlighted innate immune receptor | 85.6 | highest-priority intervention target | iPSC-derived microglia and neuron-microglia co-culture | TNF/IL6/IL1B release, NF-kB activation, neuronal toxicity | CHEMBL3301399 | 7 | https://alphafold.ebi.ac.uk/entry/O60603 | Validate immune modulation in iPSC-derived microglia/neuron co-culture using cytokines, NF-kB/stress markers, and neuronal toxicity. |
IL17A | IL-17 inflammatory signalling | Reactome-highlighted cytokine pathway node | 82 | highest-priority intervention target | microglia/astrocyte inflammatory co-culture | IL-17 response genes, cytokine release, neuronal stress markers | CHEMBL3390822 | 36 | https://alphafold.ebi.ac.uk/entry/Q16552 | Validate immune modulation in iPSC-derived microglia/neuron co-culture using cytokines, NF-kB/stress markers, and neuronal toxicity. |
PINK1 | mitochondrial quality control | mitophagy kinase and recessive PD gene | 78.7 | highest-priority intervention target | PINK1 knockout iPSC dopaminergic neurons | mitophagy reporter, mitochondrial membrane potential, ATP/ROS | CHEMBL3337330 | 3 | https://alphafold.ebi.ac.uk/entry/Q9BXM7 | Use iPSC dopaminergic neurons with mitochondrial stress and mitophagy/respiration/ROS assays. |
NTRK1 | NTRK/neurotrophin signalling | Reactome-highlighted trophic signalling node | 78 | highest-priority intervention target | dopaminergic neuron survival/trophic support model | neurite length, survival, phospho-ERK/AKT | CHEMBL2815 | 0 | https://alphafold.ebi.ac.uk/entry/A0A6Q8PF65 | Run target-specific perturbation in dopaminergic neuron survival/trophic support model using neurite length, survival, phospho-ERK/AKT. |
MAPK1 | MAP kinase activation | Reactome-highlighted signalling hub | 78 | highest-priority intervention target | stress-response assay in neurons and microglia | phospho-ERK, inflammatory/stress response, toxicity counterscreen | CHEMBL4040 | 0 | https://alphafold.ebi.ac.uk/entry/Q499G7 | Run target-specific perturbation in stress-response assay in neurons and microglia using phospho-ERK, inflammatory/stress response, toxicity counterscreen. |
NOD2 | NOD1/2 inflammatory signalling | Reactome-highlighted innate immune sensor | 75 | strong validation target | iPSC-derived microglia or monocyte-derived macrophages | NOD ligand response, cytokines, inflammasome-related markers | CHEMBL1293266 | 0 | https://alphafold.ebi.ac.uk/entry/A0A3S6A229 | Validate immune modulation in iPSC-derived microglia/neuron co-culture using cytokines, NF-kB/stress markers, and neuronal toxicity. |
NDUFS3 | mitochondrial oxidative phosphorylation | complex I pathway marker from pilot omics | 66.5 | strong validation target | iPSC dopaminergic neuron mitochondrial stress model | Seahorse OCR, complex I activity, ATP/ROS | CHEMBL6067008 | 0 | https://alphafold.ebi.ac.uk/entry/E9PS48 | Use iPSC dopaminergic neurons with mitochondrial stress and mitophagy/respiration/ROS assays. |
LAMP2 | lysosome/autophagy | lysosomal/autophagy marker | 66.5 | strong validation target | iPSC dopaminergic neurons with lysosomal stress | LC3/p62 flux, lysosomal pH, autophagosome clearance | CHEMBL5465542 | 0 | https://alphafold.ebi.ac.uk/entry/A0A9L9PXQ4 | Run target-specific perturbation in iPSC dopaminergic neurons with lysosomal stress using LC3/p62 flux, lysosomal pH, autophagosome clearance. |
MYD88 | innate immune signalling | TLR adaptor in Reactome MyD88/MAL cascade | 64.2 | strong validation target | iPSC-derived microglia inflammatory challenge | NF-kB reporter, cytokine release, rescue of co-culture toxicity | CHEMBL5919 | 0 | https://alphafold.ebi.ac.uk/entry/A0A0A0MSI9 | Validate immune modulation in iPSC-derived microglia/neuron co-culture using cytokines, NF-kB/stress markers, and neuronal toxicity. |
PRKN | mitochondrial quality control | E3 ligase and recessive PD gene | 64 | strong validation target | PRKN knockout iPSC dopaminergic neurons | mitophagy reporter, ubiquitination, mitochondrial stress survival | null | 0 | https://alphafold.ebi.ac.uk/entry/A0A669KBE3 | Use iPSC dopaminergic neurons with mitochondrial stress and mitophagy/respiration/ROS assays. |
Parkinson's Disease Discovery Benchmark Dashboard
Reusable benchmark, knowledge graph, manuscript resource, and Streamlit dashboard for Parkinson's disease target-to-intervention discovery.
This repository integrates evidence-synthesis priority scores, target tractability, omics/pathway recurrence, ChEMBL compound activity, RDKit physicochemical heuristics, Human Protein Atlas cell-type context, iPSC/stem-cell validation mappings, and publication-ready figures.
Scientific Scope
This is a research and hypothesis-generation resource. It is not clinical decision support, not a prevention guideline, not a treatment recommendation system, and not evidence that any intervention prevents or cures Parkinson's disease.
Main Assets
data/pd_discovery_target_benchmark.csvdata/compound_selectivity_safety_matrix.csvdata/validated_repurposing_candidates.csvdata/do_not_prioritise_or_comparator_compounds.csvdata/experimental_validation_matrix.csvdata/omics_recurrence/pd_multi_dataset_pathway_recurrence.csvdata/pd_discovery_benchmark_knowledge_graph.graphmldata/benchmark_graph_nodes.csvdata/benchmark_graph_edges.csvfigures/benchmark_target_ranking.pngfigures/benchmark_evidence_matrix.pngfigures/compound_selectivity_safety_triage.pngfigures/benchmark_knowledge_graph.pngdashboard/app.pyreports/resource_manuscript_target_to_intervention_benchmark.md
Run The Dashboard
pip install -r requirements.txt
streamlit run dashboard/app.py
Validate The Repository
python scripts/04_validate_resource.py
python -m py_compile dashboard/app.py
GitHub Actions runs these checks on push and pull request.
Rebuild
The complete rebuild expects the upstream folders to sit beside this repository:
PD_AI_Evidence_to_Discovery_ProjectPD_Target_to_Intervention_Discovery_Extension
Then run:
python scripts/01_build_benchmark.py
python scripts/02_finalize_resource_outputs.py
Rscript scripts/03_multi_dataset_omics_recurrence.R
Appropriate Reuse
- benchmark target-prioritisation and drug-repurposing algorithms;
- inspect candidate target, compound, and validation-model links;
- design iPSC-derived dopaminergic-neuron or glial co-culture experiments;
- compare knowledge-graph scoring methods;
- teach reproducible translational bioinformatics.
Citation
Use the metadata in CITATION.cff. If using the dataset mirrors, cite the corresponding Hugging Face or Kaggle landing page together with the commit or dataset version used.
Public Mirrors
- GitHub release: https://github.com/hssling/pd-discovery-benchmark-dashboard/releases/tag/v1.0.0
- Hugging Face Datasets: https://huggingface.co/datasets/hssling/pd-discovery-benchmark-dashboard
- Kaggle Datasets: https://www.kaggle.com/datasets/jkhospital/pd-discovery-benchmark
- Downloads last month
- 184